BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 187141)

  • 1. AKR mouse leukemic cells in tissue culture. II. Immunologic studies on the AKR 87 cell line.
    Duś D; Harlozińska A; Skriabin A; Richter R
    Arch Immunol Ther Exp (Warsz); 1976; 24(5):727-40. PubMed ID: 187141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AKR mouse leukemia cells in tissue culture. I. Establishment of leukemic cell line AKR 87 and its morphologic and biologic characteristics.
    Duś D
    Arch Immunol Ther Exp (Warsz); 1976; 24(5):713-25. PubMed ID: 187140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonal heterogeneity of anti-AKR/gross leukemia virus cytotoxic T lymphocytes. Evidence for two distinct antigen systems.
    Azuma H; Phillips JD; Green WR
    J Immunol; 1987 Oct; 139(7):2464-73. PubMed ID: 2821116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The specificity of H-2-restricted cytotoxic T lymphocytes directed to AKR/Gross leukemia virus-induced tumors. III. Coordinate alterations in viral gp70 antigen expression and restoration of CTL-susceptibility to insusceptible variant tumors.
    Manjunath R; Graziano RF; Green WR
    J Immunol; 1986 Mar; 136(6):2271-9. PubMed ID: 3005407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells.
    Green WR
    J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. II. Negative control by the Fv-1 locus in AKR mice of responder H-2b haplotype.
    Green WR
    J Immunol; 1984 May; 132(5):2665-71. PubMed ID: 6425410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of CTL-defined, AKR/Gross retrovirus-associated tumor antigens by normal spleen cells: control by Fv-1, H-2, and proviral genes and effect on antiviral CTL generation.
    Green WR
    J Immunol; 1986 Jan; 136(1):308-12. PubMed ID: 2999246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specificity of cytolytic T cells directed against AKR/Gross virus-induced syngeneic leukemias: antibodies directed against H-2K, but not against viral proteins, inhibit lysis.
    Green WR; Nowinski RC; Henney CS
    J Immunol; 1980 Aug; 125(2):647-55. PubMed ID: 6156211
    [No Abstract]   [Full Text] [Related]  

  • 9. A discrepancy in XC and oncogenicity assays for murine leukemia virus in AKR mice.
    Hays EF; Vredevoe DL
    Cancer Res; 1977 Mar; 37(3):726-30. PubMed ID: 189912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the virions in the in vitro L1210(V) leukemia cell lines by morphological, virological, and immunological techniques.
    Chen PL; Hutchison DJ; Sarkar NH; Kramarsky B; Moore DH
    Cancer Res; 1975 Mar; 35(3):718-28. PubMed ID: 163689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. I. H-2-encoded dominant gene control.
    Green WR
    J Immunol; 1984 May; 132(5):2658-64. PubMed ID: 6425409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical analysis of a novel H-2 class I-like glycoprotein expressed in five AKR-(Gross virus) derived spontaneous T cell leukemias.
    Labeta MO; Fernandez N; Reyes A; Ferrara P; Marelli O; Le Roy E; Houlihan J; Festenstein H
    J Immunol; 1989 Aug; 143(4):1245-53. PubMed ID: 2473124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serological analysis of cell surface antigens of tumors induced by murine leukemia virus.
    Herberman RB
    J Natl Cancer Inst; 1972 Jan; 48(1):265-71. PubMed ID: 4119883
    [No Abstract]   [Full Text] [Related]  

  • 14. Correlation between various cell-surface antigens induced by murine leukemia virus in the rat: serological analysis.
    Kuzumaki N
    Hokkaido Igaku Zasshi; 1975 May; 50(3):304-10. PubMed ID: 172420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AKR murine leukemia viruses and long-term bone marrow cultures from AKR and SJL mice.
    Hays EF; Warren J; Hale L; Rodensky D
    Exp Hematol; 1980 Jan; 8(1):134-46. PubMed ID: 6250871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Redistribution and modulation of Gross murine leukemia virus antigens induced by specific antibodies.
    Ioachim HL; Sabbath M
    J Natl Cancer Inst; 1979 Jan; 62(1):169-80. PubMed ID: 281570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presence of antibody against mouse fetal antigen in the sera from C57BL-6 mice immunized with Rauscher leukemia.
    Ishimoto A; Ito Y
    Cancer Res; 1972 Nov; 32(11):2332-7. PubMed ID: 4343227
    [No Abstract]   [Full Text] [Related]  

  • 18. The in vitro generation of H-2-restricted cytotoxic T cells to AKR/Gross leukemia virus-induced tumors. I. Requirement for stimulation with allogeneic leukemia cells in vivo.
    Green WR
    J Immunol; 1982 Mar; 128(3):1043-9. PubMed ID: 6976986
    [No Abstract]   [Full Text] [Related]  

  • 19. G(AKSL2): a new cell surface antigen of the mouse related to the dualtropic mink cell focus-inducing class of murine leukemia virus detected by naturally occurring antibody.
    Stockert E; DeLeo AB; O'Donnell PV; Obata Y; Old LJ
    J Exp Med; 1979 Jan; 149(1):200-15. PubMed ID: 216764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of nonresponsiveness to AKR/Gross leukemia virus in AKR.H-2b:Fv-1b mice. An analysis of precursor cytotoxic T lymphocyte frequencies in young versus moderately aged mice.
    Wegmann KW; McMaster JS; Green WR
    J Immunol; 1991 Apr; 146(7):2469-77. PubMed ID: 2005406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.